380 related articles for article (PubMed ID: 34501271)
1. Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential.
Márquez AB; van der Vorst EPC; Maas SL
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501271
[TBL] [Abstract][Full Text] [Related]
2. Targeting the chemokine network in atherosclerosis.
Yan Y; Thakur M; van der Vorst EPC; Weber C; Döring Y
Atherosclerosis; 2021 Aug; 330():95-106. PubMed ID: 34247863
[TBL] [Abstract][Full Text] [Related]
3. Chemokines and their receptors in Atherosclerosis.
van der Vorst EP; Döring Y; Weber C
J Mol Med (Berl); 2015 Sep; 93(9):963-71. PubMed ID: 26175090
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.
Nagar N; Naidu G; Panda SK; Gulati K; Singh RP; Poluri KM
Mech Ageing Dev; 2024 May; 220():111944. PubMed ID: 38782074
[TBL] [Abstract][Full Text] [Related]
5. Atypical Chemokine Receptors in Cardiovascular Disease.
Gencer S; van der Vorst EPC; Aslani M; Weber C; Döring Y; Duchene J
Thromb Haemost; 2019 Apr; 119(4):534-541. PubMed ID: 30716778
[TBL] [Abstract][Full Text] [Related]
6. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis.
Murayama MA; Shimizu J; Miyabe C; Yudo K; Miyabe Y
Front Immunol; 2023; 14():1100869. PubMed ID: 36860872
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications.
Kanzler I; Liehn EA; Koenen RR; Weber C
Curr Pharm Biotechnol; 2012 Jan; 13(1):37-45. PubMed ID: 21470163
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Chemokines in Atherosclerosis.
Gencer S; Evans BR; van der Vorst EPC; Döring Y; Weber C
Cells; 2021 Jan; 10(2):. PubMed ID: 33503867
[TBL] [Abstract][Full Text] [Related]
10. Regulation of atherosclerotic plaque inflammation.
Bäck M; Weber C; Lutgens E
J Intern Med; 2015 Nov; 278(5):462-82. PubMed ID: 25823439
[TBL] [Abstract][Full Text] [Related]
11. Chemokines as Therapeutic Targets in Cardiovascular Disease.
Noels H; Weber C; Koenen RR
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):583-592. PubMed ID: 30760014
[TBL] [Abstract][Full Text] [Related]
12. The Role of Chemokines in Cardiovascular Diseases and the Therapeutic Effect of Curcumin on CXCL8 and CCL2 as Pathological Chemokines in Atherosclerosis.
Hedayati-Moghadam M; Hosseinian S; Paseban M; Shabgah AG; Gholizadeh J; Jamialahmadi T; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1328():155-170. PubMed ID: 34981477
[TBL] [Abstract][Full Text] [Related]
13. Chemokines: established and novel targets in atherosclerosis.
Koenen RR; Weber C
EMBO Mol Med; 2011 Dec; 3(12):713-25. PubMed ID: 22038924
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in vascular pathology (review).
Apostolakis S; Papadakis EG; Krambovitis E; Spandidos DA
Int J Mol Med; 2006 May; 17(5):691-701. PubMed ID: 16596249
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias.
Apostolakis S; Amanatidou V; Spandidos DA
Acta Pharmacol Sin; 2010 Sep; 31(9):1103-10. PubMed ID: 20711227
[TBL] [Abstract][Full Text] [Related]
16. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
Bursill CA; Channon KM; Greaves DR
Curr Opin Lipidol; 2004 Apr; 15(2):145-9. PubMed ID: 15017357
[TBL] [Abstract][Full Text] [Related]
17. Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic mice.
Krammer C; Yang B; Reichl S; Besson-Girard S; Ji H; Bolini V; Schulte C; Noels H; Schlepckow K; Jocher G; Werner G; Willem M; El Bounkari O; Kapurniotu A; Gokce O; Weber C; Mohanta S; Bernhagen J
FASEB J; 2023 Mar; 37(3):e22752. PubMed ID: 36794636
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CCR5: from AIDS to atherosclerosis.
Jones KL; Maguire JJ; Davenport AP
Br J Pharmacol; 2011 Apr; 162(7):1453-69. PubMed ID: 21133894
[TBL] [Abstract][Full Text] [Related]
19. Role of the chemokine system in liver fibrosis: a narrative review.
Poulsen KL; Cajigas-Du Ross CK; Chaney JK; Nagy LE
Dig Med Res; 2022 Jun; 5():. PubMed ID: 36339901
[TBL] [Abstract][Full Text] [Related]
20. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.
Kodali R; Hajjou M; Berman AB; Bansal MB; Zhang S; Pan JJ; Schecter AD
Cardiovasc Res; 2006 Feb; 69(3):706-15. PubMed ID: 16343467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
